Impairment of blood brain barrier is related with the neuroinflammation induced peripheral immune status in intracerebroventricular colchicine injected rats: An experimental study with mannitol

Brain Research

Volumn 1646, Issue , 2016, Pages 278-286

  Sil, Susmita ^a   Ghosh, Arijit ^a   Ghosh, Tusharkanti ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Blood brain barrier; Colchicine; Mannitol; Peripheral immune responses; Serum inflammatory markers

Indexed keywords

COLCHICINE; INTERLEUKIN 1BETA; MANNITOL; NITRITE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNE STATUS; LEUKOCYTE; LEUKOCYTE INHIBITION INDEX; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; ALZHEIMER DISEASE; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; IMMUNOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOUSE; SPLEEN;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; COLCHICINE; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1BETA; LEUKOCYTES; MALE; MANNITOL; MICE; PHAGOCYTOSIS; RATS; REACTIVE OXYGEN SPECIES; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84975493727     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.05.052     Document Type: Article

References (56)

1. N.J. Abbott, and P.A. Revest Control of brain endothelial permeability Cerebrovasc. Brain Metab. Rev. 3 1991 39 72
2. T.J. Abbruscato, and T.P. Davis Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact Brain Res. 842 1999 277 286
3. J.S. Alexander, O.W. Blaschuk, and F.R. Haselton An N-cadherin-like protein contributes to solute barrier maintenance in cultured endothelium J. Cell. Physiol. 156 1993 610 618
4. A. Alvarez, R. Cacaelos, C. Sanpedro, M. García-Fantini, and M. Aleixandre Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease Neurobiol. Aging 28 2007 533 536
5. Y. Ando-Akatsuka, S. Yonemura, M. Itoh, M. Furuse, and S. Tsukita Differential behavior of E-cadherin and occludin in their colocalization with ZO-1 during the establishment of epithelial cell polarity J. Cell. Physiol. 179 1999 115 125
6. W.A. Banks, A.M. Gray, M.A. Erickson, T.S. Salameh, M. Damodarasamy, N. Sheibani, J.S. Meabon, E.E. Wing, Y. Morofuji, D.G. Cook, and M.J. Reed Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit J. Neuroinflamm. 12 2015 1 15
7. G.L. Bowman, J.A. Kaye, M. Moore, D. Waichunas, N.E. Carlson, and J.F. Quinn Blood-brain barrier impairment in Alzheimer disease: stability and functional significance Neurology 68 2007 1809 1814
8. M. Britschgi, and T. Wyss-Coray Systemic and acquired immune responses, in Alzheimer's disease Int. Rev. Neurobiol. 82 2007 205 233
9. + or albumin Brain Res. 1014 2004 221 227
10. 2 supply/consumption heterogeneity J. Cereb. Blood Flow Metab. 16 1996 327 333
11. W.C. Cosolo, P. Martinello, W.J. Louis, and N. Chrisophidis Blood-brain barrier disruption using mannitol: time course and electron microscopy studies Am. J. Physiol. 256 1989 443 447
12. C. Csolle, and B. Sperlagh Peripheral origin of IL-1β production in rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and regulation by P2×7 receptors J. Neuroimmunol. 219 2010 38 46
13. C. Csölle, and B. Sperlagh Endocannabinergic modulation of IL-1β in mouse hippo-campus under basal conditions and after in vivo systemic LPS stimulation Neuroimmunomodulation 18 2011 226 231
14. D.B. Degena, T. Müller, W. Kuhn, M. Gerlach, H. Przuntek, and P. Riederer May Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients Neurobiol. Aging 28 2007 533 536
15. H.E. de Vries, J. Kuiper, A.G. De Boer, T.J.C. Van Berkel, and D.D. Breimer The blood-brain barrier in neuroinflammatory diseases Pharmacol. Rev. 49 1997 143 155
16. M. Furuse, T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, and S. Tsukita Occludin: a novel integral membrane protein localizing at tight junctions J. Cell Biol. 123 1993 1777 1788
17. R. Ganguly, and D. Guha Alzheimer's disease and protection by Moringa oleifera Indian J. Med. Res. 128 2008 744 751
18. 15N] nitrate in biological fluids Anal. Biochem. 126 1982 131 138
19. B.M. Gumbiner Cell adhesion: the molecular basis of tissue architecture and morphogenesis Cell 84 1996 345 357
20. C.K. Hsu, C.C. Hsu, J.Y. Lee, Y.M. Kuo, and M.C. Pai Exacerbation of psoriatic skin lesions in a patient with Alzheimer disease receiving gamma-secretase inhibitor J. Am. Acad. Dermatol. 68 2013 46 48
21. M. Huberman, F. Shalit, I. Roth-Deri, B. Gutman, C. Brodie, H.E. Ko, and B. Sredini Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage J. Neuroimmunol. 52 1999 147 152
22. K.A. Jellinger, and C. Bancher AD neuropathology Neurology 46 1996 1186 1187
23. S. Joshi, A. Ergin, M. Wang, R. Reif, J. Zhang, J.N. Bruce, and I.J. Bigio Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy J. Neurooncol. 104 2011 11 19
24. G.Z. Justo, N. Duran, and M.L.S. Queiroz Myelopoietic response in tumor-bearing mice by an aggregated polymer isolated from Aspergillus oryzae Eur. J. Pharmacol. 388 2000 219 226
25. M. Kalia Dysphagia and aspiration pneumonia in patients with Alzheimer's disease Metabolism 52 2003 36 38
26. A.R. Kamer, A.P. Dasanayake, R.G. Craig, L. Glodzik-Sobanska, M. Bry, and M.J. de Leon Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis J. Alzheimers Dis. 13 2008 437 449
27. H.K. Kimelberg, T. Jalonen, and W. Walz Regulation of the brain microenvironment: transmitters and ions S. Murphy, Astrocytes: Pharmacology and Function 1993 Academic Press San Diego: CA 193 222
28. A. Kumar, N. Seghal, P.S. Naidu, S.S.V. Padi, and R. Goyal Colchicine induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type Pharmacol. Rep. 59 2007 274 283
29. R.A. Lawal, M.D. Ozaslan, O.S. Odesanmi, I.D. Karagoz, I.H. Kilic, and O.A.T. Ebuehi Cytotoxic and antiproliferative activity of Securidaca longepedunculata aqueous extract on Ehrlich ascites carcinoma cells in Swiss albino mice Int. J. Appl. Res. Nat. Prod. 5 2013 19 27
30. W. Lin, R.P. Paczynski, K. Kuppusamy, C.Y. Hsu, and E.M. Haacke Quantitative measurements of regional cerebral blood volume using MRI in rats: effects of arterial carbon dioxide tension and mannitol Magn. Reson. Med. 38 1997 420 428
31. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with Folin phenol reagent J. Biol. Chem. 193 1951 265 275
32. A.E. Maluish, and W.J. Halliday Hemocytometer leukocyte adherence technique Cancer Res. 39 1979 625 626
33. D.J. Mujsce, J. Towfighi, D. Stern, and R.C. Vannucci Mannitol therapy in perinatal hypoxic-ischemic brain damage in rats Stroke 21 1990 1210 1214
34. L.L. Muldoon, C. Soussain, K. Jahnke, C. Johanson, T. Tiegal, Q.R. Smith, W. Hall, K. Hynynen, P. Senter, D.M. Peereboom, and E.A. Neuwelt Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check J Clinical Oncol 25 2007 2295 2305
35. A. Nazem, R. Sankowski, M. Bacher, and Y. Al-Abed Rodent models of neuroinflammation for Alzheimer's disease J. Neuroinflamm. 12 2015 2 15
36. D.G. Nicola, J. Teeling, C. Guaza, J.P. Godbout, and D.D. Taub The Role of Inflammatory Mediators in Immune-to-Brain Communication during Health and Disease Mediators of Inflammation 2013 10.1155/2013/429231 Article ID 429231
37. L.E. Nicolle Urinary tract infection in long-term-care facility residents T.T. Yoshikawa, Clinical Infectious Diseases 31 2000 757 761
38. J.A. Oben, and J.C. Foreman A simple quantitative fluorimetric assay of in vitro phagocytocis in human neutrophils J. Immunol. Methods 112 1998 99 103
39. R.P. Paczynski, Y.Y. He, M.N. Diringer, and C.Y. Hsu Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction Stroke 28 1997 1437 1443 Discussion 1444
40. G.Y. Pan, X.D. Liu, and G.Q. Liu Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats Acta Pharmacol. Sin. 21 2000 613 616
41. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press San Diego
42. V. Pitchaimani, S. Arumugam, R.A. Thandavarayan, M.K. Thiyagarajan, R. Aiyalu, R. Sreedhar, T. Nakamura, and J.K. Watanabe Nootropic activityof aceta-minophen against colchicine induced cognitive impairment in rats Clin. Biochem. Nutr. 50 2012 241 244
43. S.I. Rapoport Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications Cell. Mol. Neurobiol. 20 2000 217 230
44. F. Shalit, B. Sredni, L. Stern, E. Kott, and M. Huberman Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients Neurosci. Lett. 174 1994 130 132
45. H. Shawkat, M.M. Westwood, A. Mortimer, and Mannitol: a review of its clinical uses Mannitol: a review of its clinical uses Br. J. Anaesth. Contin. Educ. Anaesth. Crit. Care Pain 12 2012 2 4
46. K. Shigematsu, and P.L. McGeer Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine Am. J. Pathol. 140 1992 787 794
47. S. Sil, T. Ghosh, and R. Ghosh NMDA receptor is involved in neuroinflammation in intracerebroventricular colchicine-injected rats J. Immunotoxicol 2016 10.3109/1547691X.2015.1130760 (In press)
48. S. Sil, and T. Ghosh Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer's disease J. Neuroimmunol. 291 2016 115 124
49. S. Sil, A.R. Goswami, G. Dutta, and T. Ghosh Effects of naproxen on some immune responses in colchicine induced rat model of Alzheimer's disease Neuroimmunomodulation 21 2014 304 321
50. D.J. Socci, K.B. Bjugstad, H.C. Jones, J.V. Pattisapu, and G.W. Arendash Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model Exp. Neurol. 155 1999 109 117
51. S.B. Soleret, M. Fioravantla, A.L. Pascale, E. Ferrari, S. Govoni, and F. Battaini Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation Neurobiol. Aging 19 1998 191 199
52. J.M. Staddon, and L.L. Rubin Cell adhesion, cell junctions and the blood-brain barrier Curr. Opin. Neurobiol. 6 1996 622 627
53. H. Wada, K. Nakajoh, T. Satoh-Nakagawa, T. Suzuki, T. Ohrui, H. Arai, and H. Sasaki Risk factors of aspiration pneumonia in Alzheimer's disease patients Gerontology 47 2001 271 276
54. E. Weidmann, J. Brieger, B. Jahn, D. Hoelzer, L. Bergmann, and P.S. Mitrou Lactate dehydrogenase-release assay: A reliable non-radioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia Ann. Hematol. 70 1995 153 158
55. A.J. Wong, and A.I. Gotlieb Endothelial cell monolayer integrity. I. Characterization of dense peripheral band of microfilaments Arteriosclerosis 6 1986 212 219
56. B.D. Zipser, C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Tavares, C.M. Hulette, M.P. Vitek, V. Hovanesian, and E.G. Stopa Microvascular injury and blood-brain barrier leakage in Alzheimer's disease Neurobiol. Aging 28 2007 977 986